1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 5,000 | 8,000 | 20:21 |
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 29.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 334 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 27.07. | ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital | 361 | Business Wire | Introduction of a minimum floor price of €4.50 per share for any future drawdown
Reduction of the maximum drawdown size from 50,000 to 2,500 shares
Immediate return of 98,026 loaned... ► Artikel lesen | |
| 23.07. | ABL Diagnostics acquires TEXCELL assets for €2.9 million | 1 | Investing.com | ||
| 23.07. | ABL Diagnostics Selected by the Évry Commercial Court to Acquire TEXCELL's Operations | 319 | Business Wire | Strengthening Life Sciences and Infectious Diseases Activities at Genopole, with Synergies in Virology, Biosafety, and Biological Control
Regulatory News:
ABL Diagnostics (Euronext Paris Compartment... ► Artikel lesen | |
| 22.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 322 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| ABL DIAGNOSTICS Aktie jetzt für 0€ handeln | |||||
| 15.07. | ABL Diagnostics Informed that its Reference Shareholder ABL Has Crossed Below the 95% Threshold | 379 | Business Wire | Methodical continuation of the free float expansion strategy, in line with the commitments set forth in the 2022 Prospectus. Boosting stock liquidity and strengthening visibility among... ► Artikel lesen | |
| 10.07. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 319 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 03.07. | Dividendenbekanntmachungen (03.07.2026) | 8.721 | wallstreetONLINE (Dividenden) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) ABL DIAGNOSTICS SA FR001400AHX6 - 0,11 EUR AGORA SA PLAGORA00067 0,5 PLN 0,1165 EUR ALBIS LEASING AG DE0006569403 - 0,1 EUR BILIA... ► Artikel lesen | |
| 02.07. | ABL Diagnostics - Approval of Dividend Distribution for Fiscal Year 2025 | 588 | Business Wire | Regulatory News:
At the Annual General Meeting of ABL Diagnostics (Paris:ABLD) held on Tuesday, June 30, 2026, at 11:00 a.m., shareholders approved all resolutions submitted for their vote, including... ► Artikel lesen | |
| 18.06. | ABL Diagnostics: Growth Trajectory Confirmed and Strong Upside Potential Identified | 435 | Business Wire | Target price: €8.7 Recommendation: Buy
Regulatory News:
ABL DIAGNOSTICS (FR001400AHX6 ABLD-FR), a leading company in the field of molecular diagnostics and genotyping, announces the... ► Artikel lesen | |
| 12.06. | ABL Diagnostics and CDL Pharma Secure a Multi-year International Contract of up to €2.7 Million Through 2031 | 463 | Business Wire | Regulatory News:
ABL Diagnostics (FR001400AHX6 "ABLD") announces the signing of a multi-year contract with a European pharmaceutical company in the field of neurodegenerative diseases. The contract... ► Artikel lesen | |
| 10.06. | ABL Diagnostics (ABLD) Announces the Submission of a Takeover Bid for Texcell France | 511 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) (Euronext Paris Compartment B ISIN: FR001400AHX6), a company specialized in molecular diagnostic solutions, healthcare software, and clinical sample... ► Artikel lesen | |
| 10.06. | ABL Diagnostics SA: ABL Diagnostics: Information Relating to the Total Number of Voting Rights and the Total Number of Shares Composing the Share Capital | 524 | Business Wire | (Articles L. 233-8, II of the French Commercial Code and 223-16 of the AMF General Regulation)
Regulatory News:
ABL Diagnostics (Paris:ABLD)
Date Total number of shares composing... ► Artikel lesen | |
| 09.06. | ABL Diagnostics: Ordinary and Extraordinary General Meeting of June 30, 2026 - Terms for Making Available or Consulting Preparatory Documents | 430 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) informs its shareholders that they are invited to attend the Ordinary and Extraordinary General Meeting to be held on Tuesday, June 30, 2026, at 11:00... ► Artikel lesen | |
| 05.06. | ABL Diagnostics SA: ABL Diagnostics: Sale of a new block of shares by its main shareholder ABL | 454 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 04.06. | ABL Diagnostics: Sale of a New Block of Shares by Its Main Shareholder ABL | 395 | Business Wire | Regulatory News:
ABL Diagnostics (Paris:ABLD) announces that its main shareholder, Advanced Biological Laboratories (ABL), a Luxembourg-based diagnostics company, has filed information with the... ► Artikel lesen | |
| 01.06. | ABL Diagnostics Presents Its Financial Roadmap and Growth Outlook for 2026 | 388 | Business Wire | Full-year 2026 revenue target set at €12.27 million, delivering an exceptional +76.5% growth compared to 2025 Historic shift in scale driven by the full-year impact of growth drivers (FTD... ► Artikel lesen | |
| 19.05. | Allinvest Reiterates Its "BUY" Rating on ABL Diagnostics and Maintains a €8.4 Target Price (Representing a 2.2X Multiple) | 384 | Business Wire | Massive upside potential of +123.4% compared to the closing price of €3.76 (as of May 18, 2026). Historic 2025 results: Revenue up +30.4% to €6.95m, net profit surging to €0.98m (+246%)... ► Artikel lesen | |
| 18.05. | ABL Diagnostics SA: ABL Diagnostics Proposes a Significant Increase in Its Dividend for FY2025 | 350 | Business Wire | Proposed dividend of €0.11 per share, up +120%, reflecting the Company's improved financial performance and solid financial position
Regulatory News:
ABL Diagnostics (Euronext Paris FR001400AHX6)... ► Artikel lesen | |
| 11.05. | ABL Diagnostics Reports Historic 2025 Annual Results: Net Income Explosion (+246%), Strong Operating Profitability and Global Acceleration | 388 | Business Wire | Strong revenue growth of +30.4% to €6.95m Positive operating income of €290k, exceeding analyst forecasts Net income soaring to nearly €1m (€987k) International business acceleration:... ► Artikel lesen |
1 2 Weiter >>
30 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 39,240 | +0,62 % | Ihre wichtigsten Termine: Spannende Zahlen von: Sony, Moderna, AbbVie, Eaton, ExxonMobil, Linde und Puma! | © Foto: picture alliance / CFOTO | CFOTOGut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine... ► Artikel lesen | |
| THERMO FISHER | 498,10 | +1,74 % | Analysts Appear Bullish on Thermo Fisher (TMO): Is The Stock Really a Buy After Earnings? | ||
| STRATEC | 20,250 | -0,49 % | STRATEC: Buy gegen Hold - was der Markt übersieht | ||
| UNIDOC HEALTH | 0,055 | +10,08 % | Ventripoint Diagnostics Ltd.: UniDoc Health and Ventripoint Diagnostics Sign MOU to Evaluate Scalable Remote Cardiac Assessment and Screening Platform | ||
| DIASORIN | 74,82 | +0,08 % | DiaSorin Reports Lower H1 Profit, Confirms FY26 Outlook | ROME (dpa-AFX) - DiaSorin S.p.A. (DIA.MI) on Friday, reported lower revenue and net profit for the first half of 2026, as higher operating expenses and weaker profitability offset growth recorded... ► Artikel lesen | |
| FRESENIUS | 46,650 | +5,16 % | Ihre wichtigsten Termine: Frische Zahlen von Ebay, Eli Lill, Allstate, Infineon, Novo Nordisk, Walt Disney | Gut geplant in den Tag. Mit dem wO-Tagesausblick haben Sie die wichtigsten Termine im Blick und starten bestens vorbereitet in den neuen Handelstag.Untermehmenstermine 06:45 Uhr, Deutschland: Basler... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 41,310 | -0,36 % | Rallye bei Palantir: Rekordjagd geht weiter: DAX startet mit Gewinnen nach Zahlenreigen | © Foto: Arne Dedert/dpaEuropas Börsen haben am Dienstag weiter zugelegt. Starke Vorgaben und die Berichtssaison stützen die Rekordstimmung. Rallye bei Palantir, in Deutschland haben Bayer, Lufthansa... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 63,10 | +0,53 % | BrightSpring Health Services, Inc. Reports Second Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., July 31, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| AUTONOMIX MEDICAL | 12,900 | -33,85 % | Morning Market Movers: Gran Tierra Energy, Autonomix Medical, Julong Holding, Shopify See Big Swings | OTTAWA (dpa-AFX) - At 7:55 a.m. ET on Wednesday, premarket trading is seeing notable activity in several stocks, with early price movements signaling potential opportunities before the opening... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 18,670 | +2,13 % | Jefferies senkt Kursziel für Procept BioRobotics nach verfehlten Eingriffszahlen | ||
| PACS GROUP | 45,720 | +1,92 % | Hohes Handelsaufkommen bei Optionen der Pacs Group | ||
| CARL ZEISS MEDITEC | 30,280 | -2,20 % | EQS-AFR: Carl Zeiss Meditec AG: Vorabbekanntmachung über die Veröffentlichung von Quartalsberichten und Quartals-/Zwischenmitteilungen | EQS Vorabbekanntmachung Finanzberichte: Carl Zeiss Meditec AG
/ Vorabbekanntmachung über die Veröffentlichung von Rechnungslegungsberichten
Carl Zeiss Meditec AG: Vorabbekanntmachung... ► Artikel lesen | |
| BILLIONTOONE | 149,77 | +5,29 % | BillionToOne Appoints Ethan Dmitrovsky, MD, as Chief Medical Officer, Oncology, to Lead Medical Strategy for Northstar | Renowned physician-scientist, former Director of Frederick National Laboratory, and one of the nation's most accomplished leaders in oncology joins BillionToOne... ► Artikel lesen | |
| GERRESHEIMER | 26,360 | -3,51 % | Der Schulden-Reset: Gerresheimer macht Kasse: 1,5 Milliarden lassen die Aktie explodieren | © Foto: Christoph Reichwein - dpaNach Bilanzprüfungen, SDAX-Abstieg und Kursdruck kommt der Befreiungsschlag: Gerresheimer verkauft zwei Sparten und will die Verschuldung senken. Gerresheimer setzt... ► Artikel lesen | |
| BLUEJAY DIAGNOSTICS | 1,490 | +49,00 % | Bluejay Diagnostics, Inc.: Bluejay Diagnostics Announces Successful Completion of Enrollment in the SYMON-II Multicenter Clinical Validation Study | ACTON, Mass., July 21, 2026 (GLOBE NEWSWIRE) -- Bluejay Diagnostics, Inc. (NASDAQ: BJDX), a medical diagnostics company developing rapid, near-patient diagnostic technologies for critical care, today... ► Artikel lesen |
Das Unternehmen ABL DIAGNOSTICS SA kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von -0,420 (-15,22 %) liegt der Kurs bei 2,340 Euro. Beim derzeitigen Kurs ergibt sich, basierend auf einer gesamten Ausschüttung von 0,22 Euro in den vergangenen 12 Monaten, eine Dividendendrendite von +9,40 %.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ABL DIAGNOSTICS SA finden Sie auf Wallstreet Online.